STAT3 and diabetic kidney disease: In addition, one of the more recently defined Mid-1 ubiquitination targets is non-receptor tyrosine phosphatase PTP1B, whose degradation leads to overactivation of the STAT3 signaling pathway and promotes inflammation and fibrosis in diabetic kidney disease (Chen Q. et al., 2021).